You're signed outSign in or to get full access.
Data Collective IV GP, LLC
Data Collective IV GP, LLC serves as the general partner of Data Collective IV, a venture capital fund headquartered in Palo Alto, California. The firm is incorporated in Delaware and manages early-stage and growth investments, primarily in deep tech companies. Founded as part of DCVC's larger organization, Data Collective IV GP focuses on financing startups in sectors such as artificial intelligence, robotics, and life sciences, leveraging interdisciplinary expertise to support innovation. The firm typically manages hundreds of millions in assets and serves institutional and high-net-worth clients seeking exposure to disruptive technologies.
Investment Strategy
Data Collective IV GP, LLC, as part of DCVC, follows a venture capital strategy that prioritizes investment in deep tech and breakthrough technology startups within fields like artificial intelligence, robotics, advanced computing, and life sciences. The firm targets early-stage companies with defensible intellectual property and potential for significant impact or market transformation. Their approach includes active engagement with portfolio companies, aiming to catalyze growth through strategic guidance and access to an experienced network of technologists, operators, and investors.
Latest 13F Filing Activity
Data Collective IV GP, LLC filed their most recent 13F report on Jun 30, 2025 disclosing 5 equity positions with a total 13F market value of $130M. The fund increased holdings in Rocket Lab Corp., Evolv Technologies Holdings, Inc., Mind Medicine (mindmed) Inc. among other positions. Data Collective IV GP, LLC reduced exposure to Rocket Lab USA, Inc., Recursion Pharmaceuticals, Inc., Roivant Sciences LTD. among others.
Top Holdings
Equity Positions (5)
| Ticker | Security | Weight | Market Value | Shares | Avg Cost | Price | Change (QoQ) |
|---|---|---|---|---|---|---|---|
E EVLV | Evolv Technologies Holdings, Inc. | 46.50% | $60.4M | 9,681,281 | $4.46 | $6.24 | +$30.2M |
R RKLB | Rocket Lab Corp | 29.82% | $38.7M | 1,083,053 | $35.77 | $35.77 | +$38.7M |
R RXRX | Recursion Pharmaceuticals, Inc. | 23.14% | $30.1M | 5,941,120 | $17.13 | $5.06 | -$1.4M |
M MNMD | Mind Medicine (MindMed) Inc. | 0.50% | $651.3K | 100,350 | $3.17 | $6.49 | +$64.2K |
R ROIV | Roivant Sciences Ltd. | 0.03% | $43.7K | 3,875 | $7.99 | $11.27 | +$4.6K |
Industry Allocation
Ask Fintool AI Agent
Get instant answers from SEC filings, earnings calls & more